Comparative evaluation of biofilm-forming capacity in uropathogenic and commensal Escherichia coli
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1570422 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Rashmi P Mahale und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysuru, India. Hauptthemen laut MEDLINE: Biofilms, Uropathogenic Escherichia coli, Urinary Tract Infections, Escherichia coli Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Escherichia coli ( E. coli ) causes most cases of the urinary tract infections (UTIs) via virulence factors like biofilms. This study identifies key phenotypic and genotypic virulence attributes of Uropathogenic Escherichia coli. Methodology A total of 180 uropathogenic E. coli (UPEC) isolated from patients with different categories (cystitis, pyelonephritis, recurrent UTI, catheter-associated UTI, and asymptomatic bacteriuria) of UTI and 30 commensal E. coli isolated from healthy individuals were evaluated for biofilm production by phenotypic methods using tissue culture plate, tube adherence, and Congo red method, and RT-PCR was used to genetically characterize them.
Results
This study analyzed 1,600 urine samples from UTI patients, with 498 showing significant bacterial growth and 180 identifying E. coli as the pathogen. The female-to-male ratio of UTI cases was 0.74. Antibiotic susceptibility testing revealed 100% sensitivity to tigecycline and fosfomycin as well as 89.44%, 86.11%, 81.66%, and 72.22% sensitivity to nitrofurantoin, amikacin, imipenem, and meropenem, respectively. Only 64.44% were sensitive to ciprofloxacin, with 10% being multidrug-resistant (MDR). Moreover, 18.33% of the UPEC isolates produced mettalo-beta-lactamases (MBL), and 13.33% produced AmpC beta-lactamases. Biofilm production was observed in 72.22% of UPEC isolates compared to 16.66% in commensal isolates. The biofilm-forming UPEC, compared to commensal E. coli , has significantly higher antibiotic resistance, with a 128-fold reduction in ciprofloxacin susceptibility. Additionally, the fimH gene was detected in 98.33% of the UPEC isolates.
Conclusion
This study shows that UPEC strains produce specific virulence determinants like adhesion to uroepithelial cells. Screening for virulence factors should be integrated into microbiology laboratories. Specific virulence genes linked to UPEC may serve as potential targets for prophylactic strategies to prevent recurrent infections and improve management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysuru, India.
- Department of Microbiology, Mysore Medical College and Research Institute, Mysuru, India.
- Quorum Sensing Laboratory, School of Chemical and Biotechnology, Sastra Deemed to be University, Thanjavur, India.
Zitieren
APA
Mahale, R. P., K, A., Princy, A., Maheshwarappa, Y. D., & Sumana, M. N. (2025). Comparative evaluation of biofilm-forming capacity in uropathogenic and commensal Escherichia coli. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1570422
Vancouver
Mahale RP, K A, Princy A, Maheshwarappa YD, Sumana MN. Comparative evaluation of biofilm-forming capacity in uropathogenic and commensal Escherichia coli. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1570422
BibTeX
@article{Mahale2025,
author = {Mahale, Rashmi P and K, Anuradha and Princy, Adeline and Maheshwarappa, Yogeesh D and Sumana, Mahadevaiah Neelambike},
title = {Comparative evaluation of biofilm-forming capacity in uropathogenic and commensal Escherichia coli},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1570422}
}
EUVIMED